FDA Charges Ahead With MDUFA III Implementation, Despite Budget Uncertainties

FDA has started carrying out its end of the medical device user fee agreement, with plans to issue several new guidance documents this fall, and the agency suggests that a short-term restriction on full user fee access should not inhibit its efforts.